# HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer

> **NCT02165605** · NA · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 28 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** HylaCare
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02165605
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02165605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02165605, "HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02165605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*